Product Information

DEXEDRINE SPANSULE 10 MG is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $22.4010 per EA under NDC 64896067410. Its NADAC has been published 115 times since Jun 12, 2019.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the dextroamphetamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DEXEDRINE SPANSULE 10 MG

dextroamphetamine sulfate
$22.4010per EA
High Outlier
DEA Schedule CII

Strength

10 mg/1

NDC

64896067410

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/20/2024

Active Ingredients

DEXTROAMPHETAMINE SULFATE

Approval Type

New Drug (NDA)

FDA Application

NDA017078

FDA Approved

Before 1982

TE Code

AB

On Market Since

8/2/1976

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXEDRINE SPANSULE 10 MG has been published 115 times since Jun 12, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$22.4010 per EA
All-time high$22.4995 (Jan 15, 2020)
All-time low$22.4010 (Oct 23, 2024)
52-week high$22.4010
52-week low$22.4010
Median price$22.4337
Average price$22.4452
Largest weekly change-0.3% (Oct 23, 2024)
Weeks tracked115
Tracking sinceJun 12, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

0.0%

3Y

-0.4%

5Y

-0.4%

All

-0.4%

Last surveyed Nov 12, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 96%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DEXEDRINE SPANSULE 10 MG?

The current National Average Drug Acquisition Cost (NADAC) for DEXEDRINE SPANSULE 10 MG, manufactured by Amneal Pharmaceuticals LLC, is $22.4010 per EA (NDC 64896067410), effective Nov 12, 2025.

How has the price of DEXEDRINE SPANSULE 10 MG changed over time?

Over the history we have for it, the NADAC for DEXEDRINE SPANSULE 10 MG has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Jun 12, 2019.

What are the highest and lowest recorded NADAC prices for DEXEDRINE SPANSULE 10 MG?

Since Jun 12, 2019, the NADAC for DEXEDRINE SPANSULE 10 MG has ranged from a low of $22.4010 (Oct 23, 2024) to a high of $22.4995 (Jan 15, 2020), with a median of $22.4337 per EA.

Are there cheaper alternatives to DEXEDRINE SPANSULE 10 MG?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMPHETAMINE ER 10 MG CAP, is $1.0065 per EA — about 96% below DEXEDRINE SPANSULE 10 MG.

Who manufactures DEXEDRINE SPANSULE 10 MG?

DEXEDRINE SPANSULE 10 MG (NDC 64896067410) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.